News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
732,650 Results
Type
Article (41733)
Company Profile (263)
Press Release (690639)
Multimedia
Podcasts (93)
Webinars (20)
Section
Business (205037)
Career Advice (2033)
Deals (35615)
Drug Delivery (130)
Drug Development (81749)
Employer Resources (173)
FDA (16538)
Job Trends (14989)
News (347299)
Policy (32792)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (5)
Academia (2606)
Accelerated approval (52)
Adcomms (28)
Allergies (172)
Alliances (49675)
ALS (213)
Alzheimer's disease (1803)
Antibody-drug conjugate (ADC) (472)
Approvals (16939)
Artificial intelligence (675)
Autoimmune disease (306)
Automation (56)
Bankruptcy (362)
Best Places to Work (11637)
BIOSECURE Act (20)
Biosimilars (223)
Biotechnology (170)
Bladder cancer (200)
Brain cancer (73)
Breast cancer (769)
Cancer (5955)
Cardiovascular disease (482)
Career advice (1727)
Career pathing (43)
CAR-T (336)
CDC (57)
Celiac Disease (3)
Cell therapy (913)
Cervical cancer (50)
Clinical research (71104)
Collaboration (2087)
Company closure (5)
Compensation (1412)
Complete response letters (83)
COVID-19 (2746)
CRISPR (108)
C-suite (1148)
Cystic fibrosis (154)
Data (8092)
Decentralized trials (3)
Denatured (28)
Depression (162)
Dermatology (91)
Diabetes (596)
Diagnostics (6955)
Digital health (56)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (329)
Drug pricing (201)
Drug shortages (31)
Duchenne muscular dystrophy (287)
Earnings (92177)
Editorial (66)
Employer branding (21)
Employer resources (152)
Events (119919)
Executive appointments (1087)
FDA (20315)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (18)
Frontotemporal dementia (35)
Funding (1742)
Gene editing (235)
Generative AI (56)
Gene therapy (727)
GLP-1 (1058)
Government (4740)
Grass and pollen (6)
Guidances (410)
Healthcare (19074)
HIV (81)
Huntington's disease (56)
IgA nephropathy (100)
Immunology and inflammation (291)
Immuno-oncology (94)
Indications (196)
Infectious disease (3093)
Inflammatory bowel disease (217)
Inflation Reduction Act (14)
Influenza (137)
Intellectual property (296)
Interviews (319)
IPO (16680)
IRA (50)
Job creations (3650)
Job search strategy (1432)
JPM (58)
Kidney cancer (19)
Labor market (102)
Layoffs (565)
Leadership (40)
Legal (7958)
Liver cancer (101)
Longevity (33)
Lung cancer (791)
Lymphoma (434)
Machine learning (60)
Management (59)
Manufacturing (1068)
MASH (198)
Medical device (13944)
Medtech (14075)
Mergers & acquisitions (20199)
Metabolic disorders (1527)
mRNA (212)
Multiple sclerosis (191)
NASH (17)
Neurodegenerative disease (426)
Neuropsychiatric disorders (105)
Neuroscience (3336)
Neurotech (1)
NextGen: Class of 2026 (6523)
Non-profit (4531)
Now hiring (78)
Obesity (708)
Opinion (288)
Ovarian cancer (229)
Pain (258)
Pancreatic cancer (311)
Parkinson's disease (370)
Partnered (33)
Patents (603)
Patient recruitment (685)
Peanut (62)
People (59679)
Pharmaceutical (58)
Pharmacy benefit managers (32)
Phase 1 (22196)
Phase 2 (31323)
Phase 3 (23278)
Pipeline (9001)
Policy (321)
Postmarket research (2577)
Preclinical (9480)
Press Release (64)
Prostate cancer (311)
Psychedelics (54)
Radiopharmaceuticals (331)
Rare diseases (1090)
Real estate (5979)
Recruiting (70)
Regulatory (25517)
Reports (57)
Research institute (2420)
Resumes & cover letters (353)
Rett syndrome (39)
RNA editing (22)
RSV (88)
Schizophrenia (178)
Series A (290)
Series B (214)
Service/supplier (11)
Sickle cell disease (112)
Special edition (24)
Spinal muscular atrophy (166)
Sponsored (48)
Startups (3651)
State (2)
Stomach cancer (19)
Supply chain (129)
Tariffs (87)
The Weekly (63)
Vaccines (1108)
Venture capital (111)
Weight loss (455)
Women's health (128)
Worklife (20)
Date
Today (183)
Last 7 days (587)
Last 30 days (3485)
Last 365 days (30268)
2026 (13437)
2025 (30188)
2024 (35235)
2023 (40095)
2022 (51216)
2021 (55761)
2020 (54120)
2019 (46577)
2018 (35039)
2017 (32144)
2016 (31509)
2015 (37587)
2014 (31361)
2013 (26389)
2012 (28624)
2011 (29312)
2010 (27386)
Location
Africa (742)
Alabama (93)
Alaska (7)
Arizona (351)
Arkansas (14)
Asia (39912)
Australia (6575)
California (13467)
Canada (3816)
China (1372)
Colorado (573)
Connecticut (583)
Delaware (414)
Europe (86294)
Florida (2014)
Georgia (433)
Hawaii (3)
Idaho (62)
Illinois (1065)
India (91)
Indiana (608)
Iowa (23)
Japan (548)
Kansas (131)
Kentucky (50)
Louisiana (44)
Maine (76)
Maryland (1610)
Massachusetts (9604)
Michigan (370)
Minnesota (726)
Mississippi (6)
Missouri (145)
Montana (33)
Nebraska (29)
Nevada (144)
New Hampshire (84)
New Jersey (3529)
New Mexico (29)
New York (3516)
North Carolina (1705)
North Dakota (9)
Northern California (6768)
Ohio (404)
Oklahoma (23)
Oregon (41)
Pennsylvania (2707)
Puerto Rico (29)
Rhode Island (50)
South America (1113)
South Carolina (86)
South Dakota (2)
Southern California (5317)
Tennessee (215)
Texas (2141)
United States (47451)
Utah (401)
Vermont (1)
Virginia (324)
Washington D.C. (80)
Washington State (1078)
West Virginia (4)
Wisconsin (129)
Wyoming (2)
732,650 Results for "anticancer inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
BriaCell Presents Robust Anti-Cancer Activity of Bria-OTS+™ in Preclinical Cancer Models
April 21, 2026
·
5 min read
Press Releases
BeyondSpring Reports Compelling New Data: Plinabulin Advances Both the Anticancer Efficacy and Safety of ADC Drugs
April 22, 2026
·
7 min read
Press Releases
MAIA Biotechnology Expects Recent $33 Million Capital Raise to Fully Fund Ongoing Pivotal Phase 3 Trial of Novel Telomere-Targeting Anticancer Therapy
April 8, 2026
·
6 min read
Press Releases
MAIA Biotechnology’s Phase 3 Momentum Demonstrates Potential Breakthrough Anticancer Opportunity in $50 Billion Immunotherapy Market
February 24, 2026
·
5 min read
Press Releases
Totus Medicines to Present Updated Phase 1 Clinical Data for TOS-358 at ESMO Targeted Anticancer Therapies Congress 2026
February 12, 2026
·
2 min read
Press Releases
Relay Therapeutics Announces Data from Zovegalisib + Fulvestrant at the Phase 3 Dose of 400mg BID Fed at ESMO Targeted Anticancer Therapies Congress 2026
March 16, 2026
·
9 min read
Press Releases
PharmaResearch Receives U.S. FDA Clearance to Initiate Phase 1 Clinical Trial of Nano Anticancer Drug, PRD-101
February 6, 2026
·
2 min read
Press Releases
BriaCell Presents Robust Anti-Cancer Activity of Bria-OTS+™ at SITC 2025
November 10, 2025
·
5 min read
Press Releases
Light-Activated Ruvidar and Interferon Demonstrate Enhanced Efficacy
Theralase(R) Demonstrates Additive Anti-Cancer Effect in Bladder Cancer In-Vitro Model when Light-Activated Ruvidar(R) is Combined with Interferon
March 2, 2026
·
6 min read
Press Releases
SN BioScience received US FDA Orphan Drug Designation for its Nano Anti-Cancer Drug ‘SNB-101' on Gastric Cancer.
December 24, 2025
·
3 min read
1 of 73,265
Next
